Tuaminoheptane

Tuaminoheptane

SCHEMBL353519

CCCCC[C@@H](C)N

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tuaminoheptane SCHEMBL354313 1.00 — —
Tuaminoheptane SCHEMBL37510 1.00 — —
SCHEMBL20495963 0.97 OPRM1 (0.94) —
SCHEMBL20495969 0.97 OPRM1 (0.94) —
SCHEMBL10771853 0.97 OPRM1 (0.94) —
Tuaminoheptane SCHEMBL23531258 0.97 — —
SCHEMBL20495961 0.97 OPRM1 (0.94) —
SCHEMBL20495958 0.97 OPRM1 (0.94) —
SCHEMBL20495967 0.97 OPRM1 (0.94) —
SCHEMBL20820762 0.97 OPRM1 (0.94) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215047-A1 MUTATED BACTERIAL STRAINS TOLERANT TO ELEVATED CONCENTRATIONS OF AMINES COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2025-10-16 — — WO claimed
WO-2022088025-A1 APPLICATION OF PANOBINOSTAT IN PREPARING DRUG FOR PREVENTION AND TREATMENT OF CORONAVIRUS 中国科学院深圳先进技术研究院 2022-05-05 — — WO claimed
WO-2022088037-A1 APPLICATION OF SIRTINOL IN PREPARATION OF DRUG FOR PREVENTING AND TREATING CORONAVIRUS 中国科学院深圳先进技术研究院 2022-05-05 — — WO claimed
WO-2022088038-A1 APPLICATION OF CAY10603 IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING CORONAVIRUS-RELATED DISEASES 中国科学院深圳先进技术研究院 2022-05-05 — — WO claimed
WO-2022088047-A1 APPLICATION OF ITF2357 IN PREPARATION OF DRUG FOR PREVENTING AND TREATING CORONAVIRUSES 中国科学院深圳先进技术研究院 2022-05-05 — — WO claimed
CN-112280761-B Recombinant transaminase, mutant of recombinant transaminase and application of mutant 清华大学 2022-04-12 — — CN claimed
CN-112280761-A Recombinant transaminase, mutant of recombinant transaminase and application of mutant 清华大学 2021-01-29 — — CN claimed
US-20160000815-A1 COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS GOSFORTH CT HOLDINGS PTY LTD (AU) 2016-01-07 — — US claimed
US-20140142140-A1 PHARMACEUTICAL COMPOSITION FOR NEUROLOGICAL DISORDERS GOSFORTH CENTRE (HOLDINGS) PTY LTD (AU) 2014-05-22 — — US claimed
EP-2729216-A1 PHARMACEUTICAL COMPOSITION FOR NEUROLOGICAL DISORDERS Gosforth Centre (Holdings) Pty Ltd (AU) 2014-05-14 — — EP claimed
WO-2008151170-A2 PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2008-12-11 — — WO claimed
EP-1987049-A1 AMPHOTERICIN DERIVATIVES ETH Zürich (CH) 2008-11-05 — — EP claimed
EP-1620442-B1 DICOPPER (I) OXALATE COMPLEXES AS PRECURSOR FOR METALLIC COPPER DEPOSITION BASF SE (DE) 2008-07-23 — — EP claimed
WO-2007096137-A1 AMPHOTERICIN DERIVATIVES ETH ZURICH (CH) 2007-08-30 — — WO claimed
EP-1620442-A1 DICOPPER (I) OXALATE COMPLEXES AS PRECURSOR FOR METALLIC COPPER DEPOSITION BASF AKTIENGESELLSCHAFT (DE) 2006-02-01 — — EP claimed
WO-2004096816-A1 DICOPPER (I) OXALATE COMPLEXES AS PRECURSOR FOR METALLIC COPPER DEPOSITION BASF AKTIENGESELLSCHAFT (DE) 2004-11-11 — — WO claimed
EP-0987332-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS Kaneka Corporation (JP) 2000-03-22 — — EP claimed
EP-0341475-B1 STEREO ISOMERS OF N-(R)-1-ARYL-ETHYL)-1-ALKYL-2,2-DICHLOROCYCLOPROPANE CARBOXAMIDE BAYER AG (DE) 1993-09-29 — — EP claimed
EP-0341475-A2 Stereo isomers of N-(R)-1-aryl-ethyl)-1-alkyl-2,2-dichlorocyclopropane carboxamide BAYER AG (DE) 1989-11-15 — — EP claimed
US-4129580-A Resolution of certain asymmetric primary amines using lasalocid HOFFMANN-LA ROCHE INC. (US) 1978-12-12 — — US claimed
Send feedback